Loading organizations...
Loading organizations...
Biotherapeutics company developing novel treatments using Pept-in technolog
Aelin Therapeutics has raised $31.8M across 1 funding round.
Aelin Therapeutics has raised $31.8M in total across 1 funding round.
Aelin Therapeutics has raised $31.8M in total across 1 funding round.
Aelin Therapeutics's investors include Boehringer Ingelheim, Fund+, John de Koning, Novartis, PMV.
Aelin Therapeutics has raised $31.8M across 1 funding round. Most recently, it raised $31.8M Series A in December 2017.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 11, 2017 | $31.8M Series A | Boehringer Ingelheim, Fund+, John de Koning, Novartis, PMV |